Industry News
LUMICKS enters collaboration with Glycostem to enhance NK cell-mediated immunotherapy
The partnership enables LUMICKS to expand on the implementation of the z-Movi to new immunotherapeutic settings
News & Articles
25
The partnership enables LUMICKS to expand on the implementation of the z-Movi to new immunotherapeutic settings